<DOC>
	<DOC>NCT00776373</DOC>
	<brief_summary>Assess the safety, tolerability and efficacy of rapamycin in combination with HiVAC in relapsed and refractory patients with aggressive lymphoid malignancies.</brief_summary>
	<brief_title>Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia, Lymphoid</mesh_term>
	<mesh_term>Burkitt Lymphoma</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Advanced lymphoid leukemia (primary refractory ALL; Relapsed ALL; CML in lymphoid accelerated phase or blast crisis; relapsed or refractory Burkitt's lymphoma; relapsed or refractory Tcell adult leukemia/lymphoma; relapsed or refractory lymphoblastic lymphoma &gt;= 18 and &lt;= 65 years of age ECOG performance status 0, 1 Life expectancy &gt;= 4 weeks Able to consume oral medication Required initial laboratory values: Creatinine &lt;= 2.0mg/dL, total or direct bilirubin &lt;= 1.5 mg/dL, SGPT(ALT) &lt;=ULN, glucose &lt; 200 mg/dL, negative pregnancy test for women with child bearing potential Subjects must not be receiving any chemotherapy agents (except Hydroxyurea) Subjects must not have received highdose AraC within 6 months of relapse Subjects must not be receiving growth factors, except for erythropoietin No currently active second malignancy other than nonmelanoma skin cancers No subjects with uncontrolled high blood pressure, unstable angina, symptomatic congestive heart failure, MI within the last 6 months or serious uncontrolled cardiac arrhythmia Subjects taking Carbamazepine, Rifabutin, Rifampin, Rifapentine, St. John's wort, Clarithromycin, Cyclosporine, Diltiazem, Erythromycin, Telithromycin, Verapamil, Tacrolimus Known HIV positivity or AIDSrelated illness Evidence of cerebellar dysfunction or prior history of cerebellar dysfunction with AraC administration Pregnant or lactating Uncontrolled infection Taking fluconazole, voriconazole, itraconazole and ketoconazole currently or within one week of study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>ALL</keyword>
	<keyword>Burkitt's Lymphoma</keyword>
	<keyword>Adult T-Cell leukemia/lymphoma</keyword>
	<keyword>Lymphoblastic leukemia</keyword>
	<keyword>CML in lymphoid blast crisis patients</keyword>
	<keyword>HiVAC</keyword>
	<keyword>Rapamycin</keyword>
</DOC>